{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:24:27Z","timestamp":1787689467881,"version":"build-2784847793"},"reference-count":91,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2015.0043","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:24:09Z","timestamp":1525253049000},"source":"Crossref","is-referenced-by-count":17,"title":["Smoking-Related Interstitial Lung Disease"],"prefix":"10.3238","author":[{"given":"Lars","family":"Hagmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Randerath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"10.3238\/arztebl.2015.0043_ref1","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, European Respiratory Society: American Thoracic Society\/European Respiratory Society International: Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277\u2013304.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"10.3238\/arztebl.2015.0043_ref2","doi-asserted-by":"crossref","unstructured":"Travis WD, Costabel U, Hansell DM, et al.: An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733\u201348.","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"10.3238\/arztebl.2015.0043_ref3","doi-asserted-by":"crossref","unstructured":"Mikuls TR, Sayles H, Yu F, et al.: Associations of cigarette smoking with rheumatoid arthritis in African Americans. Arthritis Rheum 2010; 62: 3560\u20138.","DOI":"10.1002\/art.27716"},{"key":"10.3238\/arztebl.2015.0043_ref4","doi-asserted-by":"crossref","unstructured":"Donaghy M, Rees AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983; 2: 1390\u20133.","DOI":"10.1016\/S0140-6736(83)90923-6"},{"key":"10.3238\/arztebl.2015.0043_ref5","doi-asserted-by":"crossref","unstructured":"Uchiyama H, Suda T, Nakamura Y, et al.: Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest 2008; 133: 1174\u201380.","DOI":"10.1378\/chest.07-2669"},{"key":"10.3238\/arztebl.2015.0043_ref6","doi-asserted-by":"crossref","unstructured":"Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM: Pulmonary Langerhans\u2019 cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25: 630\u20136.","DOI":"10.1097\/00000478-200105000-00010"},{"key":"10.3238\/arztebl.2015.0043_ref7","doi-asserted-by":"crossref","unstructured":"Favara BE, Feller AC, Pauli M, et al.: Contemporary classification of histiocytic disorders. The WHO committee on histiocytic\/reticulum cell proliferations. Reclassification working group of the histiocyte society. Med Pediatr Oncol 1997; 29: 157\u201366.","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C"},{"key":"10.3238\/arztebl.2015.0043_ref8","doi-asserted-by":"crossref","unstructured":"Yousem SA, Dacic S, Nikiforov YE, Nikiforova M: Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 2013; 143: 1679\u201384.","DOI":"10.1378\/chest.12-1917"},{"key":"10.3238\/arztebl.2015.0043_ref9","doi-asserted-by":"crossref","unstructured":"Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF: Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Thorax 2009; 64: 274\u20135.","DOI":"10.1136\/thx.2008.108944"},{"key":"10.3238\/arztebl.2015.0043_ref10","doi-asserted-by":"crossref","unstructured":"Haroche J, Cohen-Aubart F, Emile JF, et al.: Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 2013; 121: 1495\u2013500.","DOI":"10.1182\/blood-2012-07-446286"},{"key":"10.3238\/arztebl.2015.0043_ref11","doi-asserted-by":"crossref","unstructured":"Myers JL, Veal CF, Shin MS, Katzenstein AL: Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987; 135: 880\u20134.","DOI":"10.1164\/arrd.1987.135.4.880"},{"key":"10.3238\/arztebl.2015.0043_ref12","doi-asserted-by":"crossref","unstructured":"Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG: Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801\u20139.","DOI":"10.1056\/NEJM197804132981501"},{"key":"10.3238\/arztebl.2015.0043_ref13","doi-asserted-by":"crossref","unstructured":"Yousem SA, Colby TV, Gaensler EA: Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64: 1373\u201380.","DOI":"10.1016\/S0025-6196(12)65379-8"},{"key":"10.3238\/arztebl.2015.0043_ref14","doi-asserted-by":"crossref","unstructured":"Verleden GM, Sels F, van Raemdonck D, Verbeken EK, Lerut T, Demedts M: Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. Eur Respir J 1998; 11: 971\u20134.","DOI":"10.1183\/09031936.98.11040971"},{"key":"10.3238\/arztebl.2015.0043_ref15","doi-asserted-by":"crossref","unstructured":"Hubbard R, Lewis S, Richards K, Johnston I, Britton J: Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284\u20139.","DOI":"10.1016\/S0140-6736(96)90465-1"},{"key":"10.3238\/arztebl.2015.0043_ref16","doi-asserted-by":"crossref","unstructured":"Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA: Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242\u20138.","DOI":"10.1164\/ajrccm.155.1.9001319"},{"key":"10.3238\/arztebl.2015.0043_ref17","unstructured":"Behr J, Gunther A, Ammenwerth W, et al.: German guideline for diagnosis and management of idiopathic pulmonary fibrosis. Pneumologie 2013; 67: 81\u2013111."},{"key":"10.3238\/arztebl.2015.0043_ref18","doi-asserted-by":"crossref","unstructured":"Raghu G, Collard HR, Egan JJ, et al.: An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788\u2013824.","DOI":"10.1164\/rccm.2009-040GL"},{"key":"10.3238\/arztebl.2015.0043_ref19","doi-asserted-by":"crossref","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, et al.: A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156: 684\u201391.","DOI":"10.7326\/0003-4819-156-10-201205150-00004"},{"key":"10.3238\/arztebl.2015.0043_ref20","doi-asserted-by":"crossref","unstructured":"Demedts M, Behr J, Buhl R, et al.: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353: 2229\u201342.","DOI":"10.1056\/NEJMoa042976"},{"key":"10.3238\/arztebl.2015.0043_ref21","doi-asserted-by":"crossref","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE, Raghu G: Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2093\u2013101.","DOI":"10.1056\/NEJMoa1401739"},{"key":"10.3238\/arztebl.2015.0043_ref22","doi-asserted-by":"crossref","unstructured":"Noble PW, Albera C, Bradford WZ, et al.: Pirfenidone in patients with idiopathic pulmonary fibrosis (capacity): two randomised trials. Lancet 2011; 377: 1760\u20139.","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"10.3238\/arztebl.2015.0043_ref23","doi-asserted-by":"crossref","unstructured":"King TE, Bradford WZ, Castro-Bernardini S, et al.: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083\u201392.","DOI":"10.1056\/NEJMoa1402582"},{"key":"10.3238\/arztebl.2015.0043_ref24","doi-asserted-by":"crossref","unstructured":"Richeldi L, du Bois RM, Raghu G, et al.: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071\u201382.","DOI":"10.1056\/NEJMoa1402584"},{"key":"10.3238\/arztebl.2015.0043_ref25","doi-asserted-by":"crossref","unstructured":"Song JW, Hong SB, Lim CM, Koh Y, Kim DS: Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011; 37: 356\u201363.","DOI":"10.1183\/09031936.00159709"},{"key":"10.3238\/arztebl.2015.0043_ref26","doi-asserted-by":"crossref","unstructured":"Ozawa Y, Suda T, Naito T, et al.: Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009; 14: 723\u20138.","DOI":"10.1111\/j.1440-1843.2009.01547.x"},{"key":"10.3238\/arztebl.2015.0043_ref27","doi-asserted-by":"crossref","unstructured":"Lee JS, Collard HR, Anstrom KJ, et al.: Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013; 1: 369\u201376.","DOI":"10.1016\/S2213-2600(13)70105-X"},{"key":"10.3238\/arztebl.2015.0043_ref28","doi-asserted-by":"crossref","unstructured":"Cottin V, Nunes H, Brillet PY, et al.: Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586\u201393.","DOI":"10.1183\/09031936.05.00021005"},{"key":"10.3238\/arztebl.2015.0043_ref29","doi-asserted-by":"crossref","unstructured":"Jankowich MD, Rounds SI: Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012; 141: 222\u201331.","DOI":"10.1378\/chest.11-1062"},{"key":"10.3238\/arztebl.2015.0043_ref30","doi-asserted-by":"crossref","unstructured":"Rhee CK, Min KH, Yim NY, et al.: Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 2013; 41: 402\u20139.","DOI":"10.1183\/09031936.00221811"},{"key":"10.3238\/arztebl.2015.0043_ref31","doi-asserted-by":"crossref","unstructured":"Shorr AF, Scoville SL, Cersovsky SB, et al.: Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004; 292: 2997\u20133005.","DOI":"10.1001\/jama.292.24.2997"},{"key":"10.3238\/arztebl.2015.0043_ref32","doi-asserted-by":"crossref","unstructured":"Kelly CA, Saravanan V, Nisar M, et al.: Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study. Rheumatology (Oxford) 2014; 53: 1676\u201382.","DOI":"10.1093\/rheumatology\/keu165"},{"key":"10.3238\/arztebl.2015.0043_ref33","doi-asserted-by":"crossref","unstructured":"Chan AL, Louie S, Leslie KO, Juarez MM, Albertson TE: Cutting edge issues in Goodpasture\u2019s disease. Clin Rev Allergy Immunol 2011; 41: 151\u201362.","DOI":"10.1007\/s12016-010-8222-2"},{"key":"10.3238\/arztebl.2015.0043_ref34","doi-asserted-by":"crossref","unstructured":"Inoue Y, Trapnell BC, Tazawa R, et al.: Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752\u201362.","DOI":"10.1164\/rccm.200708-1271OC"},{"key":"10.3238\/arztebl.2015.0043_ref35","doi-asserted-by":"crossref","unstructured":"Tazawa R, Trapnell BC, Inoue Y, et al.: Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010; 181: 1345\u201354.","DOI":"10.1164\/rccm.200906-0978OC"},{"key":"10.3238\/arztebl.2015.0043_ref36","doi-asserted-by":"crossref","unstructured":"Huppmann P, Sczepanski B, Boensch M, et al.: Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2013; 42: 444\u201353.","DOI":"10.1183\/09031936.00081512"},{"key":"10.3238\/arztebl.2015.0043_ref37","doi-asserted-by":"crossref","unstructured":"Magnussen H, Kirsten AM, Kohler D, et al.: Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine. Pneumologie 2008; 62: 748\u201356.","DOI":"10.1055\/s-2008-1038290"},{"key":"10.3238\/arztebl.2015.0043_ref38","doi-asserted-by":"crossref","unstructured":"Orens JB, Estenne M, Arcasoy S, et al.: International guidelines for the selection of lung transplant candidates: 2006 update\u2014a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745\u201355.","DOI":"10.1016\/j.healun.2006.03.011"},{"key":"10.3238\/arztebl.2015.0043_ref39","doi-asserted-by":"crossref","unstructured":"Jankowich MD, Polsky M, Klein M, Rounds S: Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75: 411\u20137.","DOI":"10.1159\/000107048"},{"key":"10.3238\/arztebl.2015.0043_ref40","doi-asserted-by":"crossref","unstructured":"Wells AU, Nicholson AG, Hansell DM: Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Thorax 2007; 62: 904\u201310.","DOI":"10.1136\/thx.2004.031021"},{"key":"10.3238\/arztebl.2015.0043_ref41","doi-asserted-by":"crossref","unstructured":"Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U: Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respir Med 2011; 105: 1908\u201316.","DOI":"10.1016\/j.rmed.2011.08.018"},{"key":"10.3238\/arztebl.2015.0043_ref42","unstructured":"Sch\u00f6nfeld N, Dirks K, Costabel U, Loddenkemper R; Wissenschaftliche Arbeitsgemeinschaft f\u00fcr die Therapie von Lungenkrankheiten: A prospective clinical multicentre study on adult pulmonary Langerhans\u2019 cell histiocytosis. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29: 132\u20138."},{"key":"10.3238\/arztebl.2015.0043_ref43","doi-asserted-by":"crossref","unstructured":"Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF: Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am J Surg Pathol 2007; 31: 947\u201352.","DOI":"10.1097\/01.pas.0000249443.82971.bb"},{"key":"10.3238\/arztebl.2015.0043_ref44","doi-asserted-by":"crossref","unstructured":"Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ: Pulmonary Langerhans\u2019 cell histiocytosis: radiologic resolution following smoking cessation. Chest 1999; 115: 1452\u20135.","DOI":"10.1378\/chest.115.5.1452"},{"key":"10.3238\/arztebl.2015.0043_ref45","doi-asserted-by":"crossref","unstructured":"Fartoukh M, Humbert M, Capron F, et al.: Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216\u201323.","DOI":"10.1164\/ajrccm.161.1.9807024"},{"key":"10.3238\/arztebl.2015.0043_ref46","doi-asserted-by":"crossref","unstructured":"Chaowalit N, Pellikka PA, Decker PA, et al.: Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004; 79: 1269\u201375.","DOI":"10.4065\/79.10.1269"},{"key":"10.3238\/arztebl.2015.0043_ref47","doi-asserted-by":"crossref","unstructured":"Travis WD, Borok Z, Roum JH, et al.: Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17: 971\u201386.","DOI":"10.1097\/00000478-199310000-00002"},{"key":"10.3238\/arztebl.2015.0043_ref48","doi-asserted-by":"crossref","unstructured":"Friedman PJ, Liebow AA, Sokoloff J: Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981; 60: 385\u201396.","DOI":"10.1097\/00005792-198111000-00001"},{"key":"10.3238\/arztebl.2015.0043_ref49","doi-asserted-by":"crossref","unstructured":"Lorillon G, Bergeron A, Detourmignies L, et al.: Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2012; 186: 930\u20132.","DOI":"10.1164\/ajrccm.186.9.930"},{"key":"10.3238\/arztebl.2015.0043_ref50","doi-asserted-by":"crossref","unstructured":"Carson DA, Wasson DB, Taetle R, Yu A: Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 1983; 62: 737\u201343.","DOI":"10.1182\/blood.V62.4.737.bloodjournal624737"},{"key":"10.3238\/arztebl.2015.0043_ref51","doi-asserted-by":"crossref","unstructured":"Dauriat G, Mal H, Thabut G, et al.: Lung transplantation for pulmonary langerhans\u2019 cell histiocytosis: a multicenter analysis. Transplantation 2006; 81: 746\u201350.","DOI":"10.1097\/01.tp.0000200304.64613.af"},{"key":"10.3238\/arztebl.2015.0043_ref52","doi-asserted-by":"crossref","unstructured":"Colby TV: Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109: 101\u20139.","DOI":"10.1093\/ajcp\/109.1.101"},{"key":"10.3238\/arztebl.2015.0043_ref53","doi-asserted-by":"crossref","unstructured":"Fraig M, Shreesha U, Savici D, Katzenstein AL: Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers and never-smokers. Am J Surg Pathol 2002; 26: 647\u201353.","DOI":"10.1097\/00000478-200205000-00011"},{"key":"10.3238\/arztebl.2015.0043_ref54","doi-asserted-by":"crossref","unstructured":"Portnoy J, Veraldi KL, Schwarz MI, et al.: Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007; 131: 664\u201371.","DOI":"10.1378\/chest.06-1885"},{"key":"10.3238\/arztebl.2015.0043_ref55","doi-asserted-by":"crossref","unstructured":"Bone RC, Wolfe J, Sobonya RE, et al.: Desquamative interstitial pneumonia following chronic nitrofurantoin therapy. Chest 1976; 69: 296\u20137.","DOI":"10.1378\/chest.69.2.296"},{"key":"10.3238\/arztebl.2015.0043_ref56","doi-asserted-by":"crossref","unstructured":"Corrin B, Price AB: Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos. Thorax 1972; 27: 324\u201331.","DOI":"10.1136\/thx.27.3.324"},{"key":"10.3238\/arztebl.2015.0043_ref57","doi-asserted-by":"crossref","unstructured":"Lougheed MD, Roos JO, Waddell WR, Munt PW: Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins. Chest 1995; 108: 1196\u2013200.","DOI":"10.1378\/chest.108.5.1196"},{"key":"10.3238\/arztebl.2015.0043_ref58","doi-asserted-by":"crossref","unstructured":"Rawbone RG, Shaw MT, Jackson JG, Bagshawe KD: Complication of methotrexate-maintained remission in lymphoblastic leukemia. Br Med J 1971; 4: 467\u20138.","DOI":"10.1136\/bmj.4.5785.467"},{"key":"10.3238\/arztebl.2015.0043_ref59","doi-asserted-by":"crossref","unstructured":"Stillwell PC, Norris DG, O\u2019Connell EJ, Rosenow EC, Weiland LH, Harrison EG: Desquamative interstitial pneumonitis in children. Chest 1980; 77: 165\u201371.","DOI":"10.1378\/chest.77.2.165"},{"key":"10.3238\/arztebl.2015.0043_ref60","doi-asserted-by":"crossref","unstructured":"Travis WD, Matsui K, Moss J, Ferrans VJ: Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24: 19\u201333.","DOI":"10.1097\/00000478-200001000-00003"},{"key":"10.3238\/arztebl.2015.0043_ref61","doi-asserted-by":"crossref","unstructured":"Flusser G, Gurman G, Zirkin H, Prinslo I, Heimer D: Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 1991; 58: 324\u20136.","DOI":"10.1159\/000195954"},{"key":"10.3238\/arztebl.2015.0043_ref62","doi-asserted-by":"crossref","unstructured":"Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G: Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810\u20136.","DOI":"10.1164\/rccm.200602-163OC"},{"key":"10.3238\/arztebl.2015.0043_ref63","doi-asserted-by":"crossref","unstructured":"Armanios MY, Chen JJ, Cogan JD, et al.: Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356: 1317\u201326.","DOI":"10.1056\/NEJMoa066157"},{"key":"10.3238\/arztebl.2015.0043_ref64","doi-asserted-by":"crossref","unstructured":"Mushiroda T, Wattanapokayakit S, Takahashi A, et al.: A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 2008; 45: 654\u20136.","DOI":"10.1136\/jmg.2008.057356"},{"key":"10.3238\/arztebl.2015.0043_ref65","unstructured":"www.clinicaltrials.gov, Stud-Ident-Nr: NCT01371305; NCT01629667; NCT01769196; NCT01890265; NCT01766817; NCT02036580; NCT01872689 (last accessed on 29 October 2014)."},{"key":"10.3238\/arztebl.2015.0043_ref66","doi-asserted-by":"crossref","unstructured":"Collard HR, Moore BB, Flaherty KR, et al.: Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 636\u201343.","DOI":"10.1164\/rccm.200703-463PP"},{"key":"10.3238\/arztebl.2015.0043_ref67","doi-asserted-by":"crossref","unstructured":"Raghu G, Freudenberger TD, Yang S, et al.: High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27: 136\u201342.","DOI":"10.1183\/09031936.06.00037005"},{"key":"10.3238\/arztebl.2015.0043_ref68","doi-asserted-by":"crossref","unstructured":"Cottin V, Le Pavec J, Prevot G, et al.: Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105\u201311.","DOI":"10.1183\/09031936.00038709"},{"key":"10.3238\/arztebl.2015.0043_ref69","doi-asserted-by":"crossref","unstructured":"Jankowich MD, Rounds S: Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010; 188: 365\u201373.","DOI":"10.1007\/s00408-010-9251-6"},{"key":"10.3238\/arztebl.2015.0043_ref70","doi-asserted-by":"crossref","unstructured":"Ryerson CJ, Hartman T, Elicker BM, et al.: Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234\u201340.","DOI":"10.1378\/chest.12-2403"},{"key":"10.3238\/arztebl.2015.0043_ref71","doi-asserted-by":"crossref","unstructured":"Mejia M, Carrillo G, Rojas-Serrano J, et al.: Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10\u20135.","DOI":"10.1378\/chest.08-2306"},{"key":"10.3238\/arztebl.2015.0043_ref72","doi-asserted-by":"crossref","unstructured":"Sauvaget E, Dellamonica J, Arlaud K, et al.: Idiopathic acute eosinophilic pneumonia requiring ECMO in a teenager smoking tobacco and cannabis. Pediatr Pulmonol 2010; 45: 1246\u20139.","DOI":"10.1002\/ppul.21314"},{"key":"10.3238\/arztebl.2015.0043_ref73","doi-asserted-by":"crossref","unstructured":"Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP: Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001; 60: 223\u20137.","DOI":"10.1136\/ard.60.3.223"},{"key":"10.3238\/arztebl.2015.0043_ref74","doi-asserted-by":"crossref","unstructured":"Cavagna L, Monti S, Grosso V, et al.: The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. Biomed Res Int 2013; 2013: 759\u201360.","DOI":"10.1155\/2013\/759760"},{"key":"10.3238\/arztebl.2015.0043_ref75","doi-asserted-by":"crossref","unstructured":"Vij R, Strek ME: Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 2013; 143: 814\u201324.","DOI":"10.1378\/chest.12-0741"},{"key":"10.3238\/arztebl.2015.0043_ref76","doi-asserted-by":"crossref","unstructured":"Dixon WG, Hyrich KL, Watson KD, et al.: Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2010; 69: 1086\u201391.","DOI":"10.1136\/ard.2009.120626"},{"key":"10.3238\/arztebl.2015.0043_ref77","doi-asserted-by":"crossref","unstructured":"Leatherman JW, Davies SF, Hoidal JR: Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 1984; 63: 343\u201361.","DOI":"10.1097\/00005792-198411000-00002"},{"key":"10.3238\/arztebl.2015.0043_ref78","doi-asserted-by":"crossref","unstructured":"Seymour JF, Presneill JJ: Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215\u201335.","DOI":"10.1164\/rccm.2109105"},{"key":"10.3238\/arztebl.2015.0043_ref79","doi-asserted-by":"crossref","unstructured":"Huizar I, Kavuru MS: Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management. Curr Opin Pulm Med 2009; 15: 491\u20138.","DOI":"10.1097\/MCP.0b013e32832ea51c"},{"key":"10.3238\/arztebl.2015.0043_ref80","doi-asserted-by":"crossref","unstructured":"Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549\u201354.","DOI":"10.1136\/thx.2007.088070"},{"key":"10.3238\/arztebl.2015.0043_ref81","doi-asserted-by":"crossref","unstructured":"Ferreira A, Garvey C, Connors GL, et al.: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442\u20137.","DOI":"10.1378\/chest.08-1458"},{"key":"10.3238\/arztebl.2015.0043_ref82","doi-asserted-by":"crossref","unstructured":"Smits JM, Nossent GD, de Vries E, et al.: Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in eurotransplant. J Heart Lung Transplant 2011; 30: 22\u20138.","DOI":"10.1016\/j.healun.2010.08.006"},{"key":"10.3238\/arztebl.2015.0043_ref83","doi-asserted-by":"crossref","unstructured":"Schonfeld N, Frank W, Wenig S, et al.: Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60: 38\u201344.","DOI":"10.1159\/000196171"},{"key":"10.3238\/arztebl.2015.0043_ref84","doi-asserted-by":"crossref","unstructured":"Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG: Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54: 1009\u201314.","DOI":"10.1136\/thx.54.11.1009"},{"key":"10.3238\/arztebl.2015.0043_ref85","doi-asserted-by":"crossref","unstructured":"Tazi A, Soler P, Hance AJ: Adult pulmonary Langerhans\u2019 cell histiocytosis. Thorax 2000; 55: 405\u201316.","DOI":"10.1136\/thorax.55.5.405"},{"key":"10.3238\/arztebl.2015.0043_ref86","doi-asserted-by":"crossref","unstructured":"Galvin JR, Franks TJ: Smoking-related lung disease. J Thorac Imaging 2009; 24: 274\u201384.","DOI":"10.1097\/RTI.0b013e3181c1abb7"},{"key":"10.3238\/arztebl.2015.0043_ref87","doi-asserted-by":"crossref","unstructured":"Costabel U, Guzman J, Bonella F, Oshimo S: Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 2007; 28: 514\u201324.","DOI":"10.1055\/s-2007-991525"},{"key":"10.3238\/arztebl.2015.0043_ref88","doi-asserted-by":"crossref","unstructured":"Kawabata Y, Takemura T, Hebisawa A, et al.: Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 2008; 52: 194\u2013202.","DOI":"10.1111\/j.1365-2559.2007.02930.x"},{"key":"10.3238\/arztebl.2015.0043_ref89","doi-asserted-by":"crossref","unstructured":"Ryu JH, Colby TV, Hartman TE, Vassallo R: Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122\u201332.","DOI":"10.1183\/09031936.01.17101220"},{"key":"10.3238\/arztebl.2015.0043_ref90","doi-asserted-by":"crossref","unstructured":"Liebow AA, Steer A, Billingsley JG: Desquamative Interstitial Pneumonia. Am J Med 1965; 39: 369\u2013404.","DOI":"10.1016\/0002-9343(65)90206-8"},{"key":"10.3238\/arztebl.2015.0043_ref91","doi-asserted-by":"crossref","unstructured":"Colby TV, Swensen SJ: Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation with HRCT. J Thorac Imaging 1996; 11: 1\u201326.","DOI":"10.1097\/00005382-199601110-00001"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:15:24Z","timestamp":1638796524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":91,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2015.0043","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]}}}